AACC Guidance Document on Biotin Interference in Laboratory Tests

Laboratory tests that use streptavidin-biotin binding mechanisms have the potential to be affected by high circulating biotin concentrations, which would produce positive and negative interference in biotinylated competitive and noncompetitive (sandwich) immunoassays, respectively. Consumption of hi...

Full description

Saved in:
Bibliographic Details
Published inThe journal of applied laboratory medicine Vol. 5; no. 3; p. 575
Main Authors Li, Danni, Ferguson, Angela, Cervinski, Mark A, Lynch, Kara L, Kyle, Patrick B
Format Journal Article
LanguageEnglish
Published England 01.05.2020
Subjects
Online AccessGet more information

Cover

Loading…
Abstract Laboratory tests that use streptavidin-biotin binding mechanisms have the potential to be affected by high circulating biotin concentrations, which would produce positive and negative interference in biotinylated competitive and noncompetitive (sandwich) immunoassays, respectively. Consumption of high-dose biotin supplements for cosmetic or health-related reasons has drawn attention to biotin interference in clinical laboratory tests. Case reports and in vivo studies show that ingestion of supplemental biotin can cause clinically significant errors in select biotinylated immunoassays. This AACC Academy document is intended to provide guidance to laboratorians and clinicians for preventing, identifying, and dealing with biotin interference. In vivo and in vitro spiking studies have demonstrated that biotin concentrations required to cause interference vary by test and by manufacturer. This document includes discussion of biotin's mechanisms for interference in immunoassays, pharmacokinetics, and results of in vitro and in vivo studies and cites examples of assays known to be affected by high biotin concentrations. This document also provides guidance recommendations intended to assist laboratories and clinicians in identifying and addressing biotin interference in laboratory testing. The recent increase in the use of high-dose biotin supplements requires laboratorians and clinicians to be mindful of the potential for biotin interference in biotinylated immunoassay-based laboratory tests. Laboratories, clinicians, regulators, and patients should work together to ensure accurate laboratory results. Laboratories have several options for identifying suspected biotin interference in specimens. Alternatively, the relatively fast elimination of biotin allows the potential for rapid follow-up specimen analysis if necessary.
AbstractList Laboratory tests that use streptavidin-biotin binding mechanisms have the potential to be affected by high circulating biotin concentrations, which would produce positive and negative interference in biotinylated competitive and noncompetitive (sandwich) immunoassays, respectively. Consumption of high-dose biotin supplements for cosmetic or health-related reasons has drawn attention to biotin interference in clinical laboratory tests. Case reports and in vivo studies show that ingestion of supplemental biotin can cause clinically significant errors in select biotinylated immunoassays. This AACC Academy document is intended to provide guidance to laboratorians and clinicians for preventing, identifying, and dealing with biotin interference. In vivo and in vitro spiking studies have demonstrated that biotin concentrations required to cause interference vary by test and by manufacturer. This document includes discussion of biotin's mechanisms for interference in immunoassays, pharmacokinetics, and results of in vitro and in vivo studies and cites examples of assays known to be affected by high biotin concentrations. This document also provides guidance recommendations intended to assist laboratories and clinicians in identifying and addressing biotin interference in laboratory testing. The recent increase in the use of high-dose biotin supplements requires laboratorians and clinicians to be mindful of the potential for biotin interference in biotinylated immunoassay-based laboratory tests. Laboratories, clinicians, regulators, and patients should work together to ensure accurate laboratory results. Laboratories have several options for identifying suspected biotin interference in specimens. Alternatively, the relatively fast elimination of biotin allows the potential for rapid follow-up specimen analysis if necessary.
Author Cervinski, Mark A
Lynch, Kara L
Ferguson, Angela
Kyle, Patrick B
Li, Danni
Author_xml – sequence: 1
  givenname: Danni
  surname: Li
  fullname: Li, Danni
  organization: Department of Lab Medicine and Pathology, University of Minnesota Medical Center, Minneapolis, MN
– sequence: 2
  givenname: Angela
  surname: Ferguson
  fullname: Ferguson, Angela
  organization: Department of Pathology and Laboratory Medicine, Children's Mercy Kansas City, Kansas City, MO
– sequence: 3
  givenname: Mark A
  surname: Cervinski
  fullname: Cervinski, Mark A
  organization: Department of Pathology and Laboratory Medicine, Geisel School of Medicine at Dartmouth, Hanover, NH
– sequence: 4
  givenname: Kara L
  surname: Lynch
  fullname: Lynch, Kara L
  organization: Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA
– sequence: 5
  givenname: Patrick B
  surname: Kyle
  fullname: Kyle, Patrick B
  organization: Department of Pathology, University of Mississippi Medical Center, Jackson, MS
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32445355$$D View this record in MEDLINE/PubMed
BookMark eNo1j71OwzAYRT0U0VI6sSO_QKh_YsceQ4BSKRJLmSvb-SwlauzKcYby9BQB09XVka7OvUOLEAMg9EDJEyWabwdzGreD_yKULNCKiUoWuhRyiTbTNBBCqGJScnKLlpyVpeBCrFBd102Dd3PfmeAAv0Q3jxAyjgE_9zH3Ae9DhuQhwQ-_9tbYmEyO6YIPMOXpHt14c5pg85dr9Pn2emjei_Zjt2_qtnCcyVwobyXRErTiQnsjjCKmcta6jlrqr_5eCG0JuMp1gkvlhWaVkx03tjLOlWyNHn93z7MdoTueUz-adDn-f2Hf4yhMIQ
CitedBy_id crossref_primary_10_1016_j_jaip_2022_05_021
crossref_primary_10_5937_mgiszm2391068M
crossref_primary_10_1007_s00216_022_04188_z
crossref_primary_10_1016_j_clinbiochem_2023_110599
crossref_primary_10_1161_JAHA_123_035128
crossref_primary_10_3390_diagnostics12051172
crossref_primary_10_17925_EE_2022_18_2_141
crossref_primary_10_3390_cimb44090297
crossref_primary_10_1016_j_jmsacl_2023_01_006
crossref_primary_10_1016_j_clinbiochem_2021_01_013
crossref_primary_10_1080_00365513_2020_1871504
crossref_primary_10_1097_PSN_0000000000000508
crossref_primary_10_1080_00365513_2021_2003854
crossref_primary_10_1016_j_jelechem_2023_117413
crossref_primary_10_1515_almed_2020_0047
crossref_primary_10_1016_j_clinbiochem_2021_10_011
crossref_primary_10_1016_j_clinbiochem_2021_10_012
crossref_primary_10_1093_jalm_jfab169
crossref_primary_10_11106_ijt_2021_14_1_46
crossref_primary_10_47429_lmo_2022_12_3_191
crossref_primary_10_1186_s13044_023_00162_8
crossref_primary_10_1093_ejendo_lvad109
crossref_primary_10_1007_s12020_020_02497_w
crossref_primary_10_1016_j_cca_2020_06_050
crossref_primary_10_1016_j_clinbiochem_2024_110747
crossref_primary_10_1089_thy_2020_0866
crossref_primary_10_1515_almed_2020_0097
crossref_primary_10_3390_diagnostics13162707
crossref_primary_10_1016_j_clinbiochem_2020_05_009
crossref_primary_10_3390_cimb45110549
crossref_primary_10_1093_jalm_jfaa167
crossref_primary_10_1016_j_jelechem_2022_116511
crossref_primary_10_1093_jalm_jfaa040
crossref_primary_10_1093_jalm_jfac042
crossref_primary_10_1093_jalm_jfad131
crossref_primary_10_3390_ijms22042140
crossref_primary_10_1016_j_cca_2023_117736
ContentType Journal Article
Copyright American Association for Clinical Chemistry 2020. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Copyright_xml – notice: American Association for Clinical Chemistry 2020. All rights reserved. For permissions, please email: journals.permissions@oup.com.
DBID NPM
DOI 10.1093/jalm/jfz010
DatabaseName PubMed
DatabaseTitle PubMed
DatabaseTitleList PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
ExternalDocumentID 32445355
Genre Journal Article
GroupedDBID 0R~
53G
5WD
AABZA
AACZT
AAPQZ
AAPXW
AARHZ
AAUAY
AAVAP
ABJNI
ABMNT
ABNHQ
ABPQP
ABPTD
ABQNK
ABXVV
ACYHN
ADGKP
ADGZP
ADIPN
ADQBN
ADVEK
AELWJ
AETBJ
AFFZL
AFGWE
AFXAL
AGINJ
AGUTN
AJEEA
ALMA_UNASSIGNED_HOLDINGS
ATGXG
BCRHZ
BEYMZ
C45
EBS
EMOBN
ENERS
FECEO
FHSFR
FLUFQ
FOEOM
FOTVD
GAUVT
H13
KBUDW
KOP
KSI
KSN
ML0
NOMLY
NPM
OAUYM
OBOKY
OCZFY
OJZSN
OPAEJ
OVD
OWPYF
R0Z
ROX
RUSNO
TCC
TEORI
YXANX
ID FETCH-LOGICAL-c326t-8fb6096e98359fa5a80a7cbbcd1b1f109f559b0ec7cd5368f5927c6d3ab7acc42
ISSN 2576-9456
IngestDate Wed Oct 16 00:45:04 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Biotin Interference
Biotin
Immunoassay Interference
Language English
License American Association for Clinical Chemistry 2020. All rights reserved. For permissions, please email: journals.permissions@oup.com.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c326t-8fb6096e98359fa5a80a7cbbcd1b1f109f559b0ec7cd5368f5927c6d3ab7acc42
OpenAccessLink https://academic.oup.com/jalm/article-pdf/5/3/575/33648071/jfz010.pdf
PMID 32445355
ParticipantIDs pubmed_primary_32445355
PublicationCentury 2000
PublicationDate 2020-May-01
PublicationDateYYYYMMDD 2020-05-01
PublicationDate_xml – month: 05
  year: 2020
  text: 2020-May-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle The journal of applied laboratory medicine
PublicationTitleAlternate J Appl Lab Med
PublicationYear 2020
SSID ssj0001826630
Score 2.3436017
Snippet Laboratory tests that use streptavidin-biotin binding mechanisms have the potential to be affected by high circulating biotin concentrations, which would...
SourceID pubmed
SourceType Index Database
StartPage 575
Title AACC Guidance Document on Biotin Interference in Laboratory Tests
URI https://www.ncbi.nlm.nih.gov/pubmed/32445355
Volume 5
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwELUoSKgXxL4jH7gG0trOcowqUAUtpyL1hmzHRkWQVhAO8PWMY7uJCojlEjVxEtl9z87MeBaETjUnkgkzkbQiASUS5hwlOugoohmJVTfSJjh5eBP1b-nVmI3r7YIquqQUZ_L9y7iS_6AK1wBXEyX7B2TnL4UL8BvwhSMgDMdfYZxlvR6APMkrv3_4Xrzarf3ClJgsJ87e5zPJwvnAQm721UfwOXhpiqaGMI08EtyJp4_1I4v78AMfpF5MGmbp-1cXxJUZf9naEcgsSr5KtokQqq2og7fCFqS65s_chUE4Q0Q3rN3-7HplVJcgpTZPuF9cWYNDpLFQMlsv5dMCbpNbPXBjEL580O-hdXptgDl7qtAEQZAywtjPrQv5tH1TC7XixBT7uHH2ncoqB9pWVBWomY_GBXVCx85Nt85tp9po1b9oQSGpBJPROlpzGgXOLD020JIqNtHq0GG1hTLDEuxZgj1L8LTAliW4yRIM5zVLcMWSbXR7eTHq9QNXOCOQII2XQaJFBKqpSkG8TjVnPAl5LIWQeUd0NAxFgx4pQiVjmTMSJZql3VhGOeEi5lLS7g5aLqaF2kM4VylPCdVwb0qjMBGE05THMYiZApRruY927eDvZjY7yp3_Ww6-bTlE7Zo_R2hFw3RUxyDbleKkguMDecBNyw
link.rule.ids 780
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=AACC+Guidance+Document+on+Biotin+Interference+in+Laboratory+Tests&rft.jtitle=The+journal+of+applied+laboratory+medicine&rft.au=Li%2C+Danni&rft.au=Ferguson%2C+Angela&rft.au=Cervinski%2C+Mark+A&rft.au=Lynch%2C+Kara+L&rft.date=2020-05-01&rft.issn=2576-9456&rft.volume=5&rft.issue=3&rft.spage=575&rft_id=info:doi/10.1093%2Fjalm%2Fjfz010&rft_id=info%3Apmid%2F32445355&rft_id=info%3Apmid%2F32445355&rft.externalDocID=32445355
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2576-9456&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2576-9456&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2576-9456&client=summon